SARS-CoV-2 Sample Collection

April 1, 2025

SARS-CoV-2 Sample Collection

During the global COVID-19 pandemic, iProcess was contracted by a major medical device/healthcare company to help prospectively collect SARS-CoV-2 samples to be used as validation materials for their novel test platform.

Challenges & Solutions

Challenge: Shortages of viral transport medium (VTM) due to high global demand.
Solution: iProcess expanded supplier partnerships, securing a reliable supply chain to prevent disruptions.
Challenge: Efficient participant recruitment to meet sample volume targets.
Solution: Implemented strategic outreach programs at clinics and hospitals to increase participation rates.

Outcome

Successfully supported the development of a new molecular diagnostic assay.
Provided high-quality specimens that met regulatory and clinical requirements.
Strengthened relationships with both the sponsor and sites for future collaborations.

Other Case Studies

April 1, 2025

Pandemic Response Sample Collection from Healthy Participants and Participants with Cancer

In response to the global COVID-19 pandemic, iProcess provided crucial support of an initiative aimed at supporting the rapid deployment and expansion of SARS-CoV-2 serological…

April 1, 2025

SARS-CoV-2 Sample Collection

During the global COVID-19 pandemic, iProcess was contracted by a major medical device/healthcare company to help prospectively collect SARS-CoV-2 samples to be used as validation…